Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials

Dong Yeop Shin, Sahee Park, Eunjung Jang, Jee Hyun Kong, Young Woong Won, Sukjoong Oh, Yunsuk Choi, Jeong A. Kim, Se Won Lee, Yeung Chul Mun, Hawk Kim, Sung Hyun Kim, Young Rok Do, Jae Yong Kwak, Hyeoung Joon Kim, Dae Young Zang, Sung Nam Lim, Won Sik Lee, Dong Wook Kim

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Early dose reduction of dasatinib does not compromise clinical outcomes in patients with chronic myeloid leukemia: A comparative analysis of two prospective trials'. Together they form a unique fingerprint.

Medicine and Dentistry

Immunology and Microbiology